Publication | Closed Access

Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma

Hematological MalignancyCd117 ExpressionMedicineMalignant Blood DisorderImmunologyHematologyPathologyMultiple MyelomaPoor PrognosisOncologyCancer Research